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Abstract
Calcium/calmodulin-dependent protein kinase II (CaMKII) is recognized as a key element in
encoding depolarization activity of excitable cells into facilitated voltage-gated Ca2+ channel
(VGCC) function. Less is known about the participation of CaMKII in regulating VGCCs in
resting cells. We examined constitutive CaMKII control of Ca2+ currents in peripheral sensory
neurons acutely isolated from dorsal root ganglia (DRGs) of adult rats. The small molecule
CaMKII inhibitor KN-93 (1.0μM) reduced depolarization-induced ICa by 16 – 30% in excess of
the effects produced by the inactive homolog KN-92. The specificity of CaMKII inhibition on
VGCC function was shown by efficacy of the selective CaMKII blocking peptide autocamtide-2-
related inhibitory peptide in a membrane-permeable myristoylated form, which also reduced
VGCC current in resting neurons. Loss of VGCC currents is primarily due to reduced N-type
current, as application of mAIP selectively reduced N-type current by approximately 30%, and
prior N-type current inhibition eliminated the effect of mAIP on VGCCs, while prior block of L-
type channels did not reduce the effect of mAIP on total ICa. T-type currents were not affected by
mAIP in resting DRG neurons. Transduction of sensory neurons in vivo by DRG injection of an
adeno-associated virus expressing AIP also resulted in a loss of N-type currents. Together, these
findings reveal a novel molecular adaptation whereby sensory neurons retain CaMKII support of
VGCCs despite remaining quiescent.
Keywords
Calcium/calmodulin-dependent protein kinase II; sensory neuron; voltage-gated calcium channel;
calcium signaling
INTRODUCTION
Voltage-gated Ca2+ channels (VGCCs) are the dominant path of activity-related Ca2+ entry
in most neurons, and thereby drive critical functions including synaptic transmission and
regulation of neuronal excitability (Berridge, 1998). Sensory neurons are equipped with a
broad range of VGCCs, including high-voltage-activated (HVA) channels as well as those
that open at low voltages (LVA). Recordings from sensory neurons, typically in somata
dissociated from the dorsal root ganglia (DRGs), demonstrate multiple subtypes of HVA
channels (McCallum et al., 2011). The largest currents are conducted through the conotoxin-
sensitive N-type channels that incorporate the pore-forming α1 subunit designated CaV2.2,
and dihydropyridine-sensitive L-type channels (CaV1.2 and 1.3). Smaller components of the
overall ensemble of voltage-gated ICa are contributed by P/Q-type (CaV2.1) that is sensitive
to agatoxin, R-type HVA current (CaV2.3) that is sensitive to toxin from tarantula venom,
and T-type LVA current (CaV3.2). Some distinct roles have been defined for particular
VGCC subtypes. Specifically, N-type current is the dominant source of Ca2+ influx for
dorsal horn neurotransmission in pain pathways (Heinke et al., 2004), while P/Q-type
current mediates synaptic transmission between inhibitory interneurons and dorsal horn
neurons (Takahashi and Momiyama, 1993). L-type current is particularly linked to signaling
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that triggers gene expression (Fossat et al., 2010), and T-type current supports repetitive
firing (Nelson et al., 2005).
Modulation of VGCC function underlies both physiological regulation of channel operation
as well as pathogenic alterations (Park and Luo, 2010). Sensitivity to G-protein (Park and
Luo, 2010) and kinase signaling systems, including Ca2+-sensitive kinases that provide
feedback regulation, are well established as pathways modulating VGCCs. A central role for
the serine/threonine protein kinase, Ca2+/calmodulin-dependent protein kinase II (CaMKII)
in Ca2+ regulation of VGCCs is suggested by its abundance in neurons, as well as
identification of CaMKII phosphorylation sites on the pore-forming α1 subunits of N- and
L-type channels (Hell et al., 1994; Hell et al., 1993). Furthermore, CaMKII enhances L- and
P/Q-type currents through both phosphorylation and structural interactions (Blaich et al.,
2010; Dzhura et al., 2000; Grueter et al., 2006; Hudmon et al., 2005; Jiang et al., 2008; Lee
et al., 2006). We have recently observed that sensory neuron activation results in CaMKII-
dependent facilitation of N-type ICa, which in turn results in a period of depressed neuronal
excitability (Tang et al., 2012). Since the regulation by CaMKII of neuronal VGCCs in the
resting state has only been minimally examined (P/Q currents in hippocampal neurons
(Jiang et al., 2008)), the experiments reported here were designed to identify if CaMKII
provides constitutive control over VGCC function in sensory neurons in the absence of prior
neuronal firing.
METHODS
Recombinant adeno-associated virus (AAV) vectors
An AAV vector was designed to encode a chimeric protein in which enhanced GFP (EGFP)
was linked to the CaMKII inhibiting peptide autocamtide-2-related inhibitory peptide (AIP)
(Ishida and Fujisawa, 1995). A DNA fragment containing the EGFP-AIP sequence from
pEGFPc1-AIP (kindly provided by Dr. Steven H. Green, Department of Biological Sciences,
University of Iowa (Bok et al., 2007)) was cloned into the NdeI/HpaI sites of pAAV-DS-
CMV, a double-strand serotype 8 AAV plasmid (Viromics, Fremont, CA), to generate
pdsAAV-CMV-EGFP-AIP. EGFP released from pEGFP-c1 was cloned into pAAV-DS-
CMV to generate pdsAAV-CMV-EGFP. AAV vectors of AAV8-EGFP-AIP and AAV8-
EGFP were produced in our laboratory by the triple-transfection of either pdsAAV-CMV-
EGFP-AIP or pdsAAV-CMV-GFP (control) with pRC8 and pHelpler (Viromics) into 293T
cells, followed by two cycles of cesium chloride gradient purification and concentrated as
previously described (Grimm et al., 2003). Encapsidated DNA was quantified by a
PicoGreen assay (Invitrogen, Carlsbad, CA) following denaturation of the AAV particles,
and the physical titer was calculated and expressed as genome copy number per ml (GC/ml).
The titers of AAV8-EGFP-AIP and AAV8-EGFP were 3.04×1012 GC/ml and 9.84×1012
GC/ml, respectively.
Animal preparation
All animal experiments were approved by the Medical College of Wisconsin Animal Care
and Use Committee. A total of 70 male Sprague-Dawley rats (Taconic, Hudson, NY, USA)
weighing 125–150 g were used. Rats were housed in individual cages under controlled
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conditions, with food and water available ad libitum. Control animals received midline
lumbar skin incision during brief general anesthesia (Isoflurane 2% in O2). Other rats were
injected with vectors AAV8-EGFP or AAV8-EGFP-AIP, as described previously (Fischer et
al., 2011). Briefly, after exposure through a midline lumbar incision, the intervertebral
foramen was enlarged by removal of laminar bone to expose the distal pole of the right 4th
lumbar (L4) and L5 DRGs. A pulled glass micropipette was advanced through the capsule
into the ganglion. Injection of vectors (2×109 viral particle in 2μl per DRG) was performed
over a 5min period using a microprocessor-controlled injector (World Precision Instruments,
Sarasota, FL, USA). This volume has been demonstrated to fill the DRG without spilling
into adjacent tissues (Fischer et al., 2011).
Neuronal dissociation
The L4 and L5 DRGs were harvested and dissociated 3 weeks after surgery in control and
injected rats. After decapitation under deep isoflurane anesthesia, DRGs were removed and
placed into a 35 mm Petri dish containing Ca2/Mg2-free, iced Hank’s balanced salt solution
– HBSS (Gibco, Life Technologies Corp, Brown Deer WI). The ganglia were cut into
several pieces, incubated for 25 min at 37°C in 0.5 mg/ml Liberase TM (Roche) in
DMEM/F12 (1:1) DMEM/Ham’s F12 (Gibco), resuspended for 10 min at 37°C in 1 mg/ml
trypsin (Sigma–Aldrich, St. Louis MO) and 15K Kunitz units DNase (Sigma–Aldrich).
Dissociated neurons were then placed in 0.1% trypsin inhibitor (Type II, Sigma–Aldrich),
centrifuged and lightly triturated in neural basal media (Gibco) containing 2% (v:v) B27
supplement (Gibco), 0.5 mM L-glutamine (G-7029, Sigma–Aldrich), 0.05 mg/ml
gentamicin (Gibco), 10 ng/ml nerve growth factor 7S (Alomone Labs Ltd., Jerusalem,
Israel), and 1.8mM Ca2+ concentration. Cells were then plated onto glass coverslips
(Carolina Biological Supply, Burlington, NC) coated with poly-L-lysine (70–150 kDa,
Sigma–Aldrich), and cultured at 37°C in humidified 95% air and 5% CO2 for at least 2 h.
Cells were used within 3–8 h after dissociation.
Whole cell patch clamp recording
Currents were recorded in the whole-cell configuration of the patch-clamp technique. Patch
pipettes, ranging from 2 to 4 MΩ resistance, were formed from borosilicate glass (King
Precision Glass, Inc, Claremont, CA) and fire polished. Currents were recorded with an
Axopatch 200B amplifier (Molecular Devices, Sunnyvale, CA), filtered at 2 kHz through a
4-pole Bessel filter, and digitized at 10 kHz with a Digidata 1320 A/D interface and pClamp
9 software (Molecular Devices). Gigaohm seals were achieved in modified Tyrode’s
solution containing (in mM): 140 NaCl, 4 KCl, 2 CaCl2, 2 MgCl2, 10 D-glucose, and 10
HEPES, pH of 7.4, with an osmolarity of 300 mOsm. Access resistance was 80–90%
compensated. Voltage-induced currents flowing through Ca2+ channels were then isolated
and recorded using an extracellular solution containing (in mM): 2 BaCl2, 5 4-
aminophyridine, 10 HEPES, 132 N-methyl-D-glucamine, 4.8 CsCl, 5 Glucose, 2 MgCl2, pH
of 7.4, with an osmolarity of 300 mOsm. Although Ba2+ was the charge carrier, we hereafter
refer to currents as ICa. The internal pipette solution contained (in mM): 110 CsCl, 20
TEACl, 5 Mg-ATP, 0.4 Li4-GTP, 11 EGTA (unless otherwise noted), 1 CaCl2, 1 MgCl2, 0.1
c-AMP, and 10 HEPES, pH of 7.2, with an osmolarity of 300 mOsm. To selectively record
low-voltage-activated T-type currents, we used a pipette solution that contained fluoride to
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facilitate high-voltage-activated ICa rundown (Todorovic and Lingle, 1998). This solution
contained tetramethylammonium hydroxide (TMA-OH) 135, EGTA 10, HEPES 40, and
MgCl2 2, adjusted to pH 7.2 with hydrofluoric acid, and with an osmolarity of 300mOsm.
Currents were activated by voltage commands in consisting of either step depolarizations or
action potential (AP) waveform depolarizations. After a test depolarization at least 1min of
membrane rest elapsed before a subsequent test depolarization. Data from whole-cell ICa
recordings were evaluated with Axograph X 1.3.5 (AxoGraph Scientific, Sydney, Australia),
with which peak inward currents were measured. The density of currents was determined by
normalizing peak current to cell capacitance (pA/pF). Current-voltage (I-V) data from
recordings during step depolarizations were fit to a Boltzmann equation in the form:
where IBa is current (not leak subtracted), GMax is the maximum channel conductance, V1/2
is the voltage at which current is half maximal, k is a slope factor describing voltage
dependence of conductance, VR is the reversal potential for current, and VM is the
membrane potential, determined separately for each cell, using Prism v. 4 (GraphPad
Software, Inc., San Diego, CA).
CaMKII catalytic assay
Following cardiac perfusion with a solution designed to avoid activation of CaMKII in
sensory neurons (in mM: 26 NaHCO3, 1.9 KCl, 1.3 MgSO4, 1.2 KH2PO4, 10 glucose, 1
EGTA, 254 sucrose aerated with 5% CO2 in oxygen, at 25°C), the L4 and L5 DRGs were
removed bilaterally from a control rat three days after skin incision and were homogenized
in 150μl of lysis buffer (Kolb et al., 1995) containing 2X protease inhibitors (Millipore,
539137) and 2X phosphatase inhibitors (Millipore, 524624), and incubated on ice for 30
minutes. The pooled lysate was spun down at 14000 rpm for 10 min at 4°C. To determine
the level of CaMKII catalytic activity, the sample was analyzed for the ability to
phosphorylate the specific CaMKII substrate AC-2 (KKALRRQETVDAL) in the presence
of 1mM Ca2+ and 5 μM calmodulin and [γ-32P]ATP (3 μCi per reaction) or 10 mM EGTA
as described previously (Kolb et al., 1995) for autonomous activity determination. The
reaction mixtures were spotted onto P81 phosphocellulose paper and the excess free-labeled
ATP γP32 was washed off by rinsing the spotted sheet (Ashpole and Hudmon 2011).
Phosphorylated AC-2 (P32 labeled) was measured using Cerenkov counting in a scintillation
counter. The background readings for each lysate (complete reactions minus AC-2) were
subtracted for the Ca2+-induced kinase activity and autonomous activity determinations. The
autonomous activity is calculated as the percentage of activity in the presence of EGTA
divided by total activity induced with saturating levels of Ca2+/calmodulin in the lysate.
Agents
All chemicals were obtained from Sigma Aldrich unless otherwise specified. Two
conventional and distinct CaMKII inhibitors were employed. KN-93 was compared to its
inactive isomer KN-92 (Calbiochem, EMD Millipore Corporation, Billerica, MA), while the
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selective peptide inhibitor AIP was used in its membrane-permeable myristoylated form
(mAIP, Calbiochem), with myristoyl-chloride (mCl) as a control, both at 5μM. HVA Ca2+
channel subtypes were isolated using selective blockers. Nisoldipine (Peptides International,
Louisville, KY) or nimodipine (Calbiochem) were used to block L-type current, SNX- 111
(synthetic ω-conotoxin MVIIA, Peptides International, Louisville, KY) to block N-type
current, ω-conotoxin MVIIC (MVIIC) for irreversible blockade of P/Q type currents and
reversible block of N-type. SNX-482 (Peptides International) blocks residual R-type current.
Non-saturating doses of these blockers were used to avoid non-specific effects (McCallum
et al., 2011), and about 20% of HVA ICa in DRG neurons remained unaffected after their
combined application, which was sensitive to the non-selective ICa blocker cadmium (200
μM, data not shown). Antagonists were delivered in the external Ba2+ solution directly to the
neuron through a pressure regulated microperfusion system (ALA-BP8 system, ALA
Scientific, Farmingdale, NY). Each neuron was exposed to only one concentration of
blocker.
KN-93 stock solution was dissolved in water, aliquoted and kept at −20°C until use. KN-92
was dissolved in DMSO and aliquoted and kept at −20°C. DMSO was present in final
solutions at a concentration 0.1%. This concentration had no effect on ICa when
administered alone (rundown with DMSO of 20.9±1.4% after 8min, n=5; without DMSO
20.3±2.8%, n=8; P=0.89), or when included in trials of KN-93 (n=5, with EGTA at 11mM),
so these data were pooled with data from DMSO-free Control or KN-93 data, respectively.
mAIP and mCl were dissolved in water, aliquoted and stored on −20°C. Nisoldipine was
dissolved in DMSO and stored at +4°C. SNX-111, SNX-482 and MVIIC were diluted in
water, lyophilized, and aliquots were stored at −80°C.
Analysis and statistics
To test statistical significance of differences between groups, one-way or two-way ANOVA
was performed where appropriate and post hoc paired comparisons were performed with
Tukey’s test using Prism (GraphPad Software). Where appropriate, 2-tailed t-tests were used
to compare findings before and after applications of agents or between groups, calculated
with Excel (Microsoft, Redmond WA). Data are presented as mean ± SEM. Effects are
considered significant for P<0.05.
RESULTS
Neuronal Activity
Dissociated sensory neurons are inactive unless depolarized from their natural resting
membrane potential, accurately reflecting the behavior of healthy sensory neurons in situ
(Bessou and Perl, 1969). In the present study, no spontaneous firing was observed
throughout the recording period of all neurons.
Effect on ICa of CaMKII inhibition by brief KN-93 application
In order to explore the effect of CaMKII regulation of ICa in resting peripheral sensory
neurons, we first employed the conventional CaMKII inhibitor KN-93 (1 μM, Fig. 1A),
which as an allosteric inhibitor prevents Ca2+-dependent CaMKII activation and
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autophosphorylation. In parallel, other neurons were exposed to the inactive isomer KN-92
to identify off-target effects of KN-93. Current rundown was monitored in neurons not
receiving either agent (Fig. 1B). Time of exposure for recording the response of ICa to these
conditions was chosen as 5min to balance allow development of the differential effect of
KN-93 vs. KN-92 while limiting progressive development of current rundown (Fig. 1B). To
maintain resting [Ca2+]c conditions throughout the recording, we buffered the internal
(pipette) solution with 2.2mM EGTA, which produced a calculated free Ca2+ concentration
of 149nM (http://maxchelator.stanford.edu) that is typical of resting sensory neurons (Fuchs
et al., 2005). Under these conditions, the inactive compound KN-92 did not influence ICa,
whereas the active CaMKII inhibitor KN-93 depressed ICa in excess of the influence of ICa
rundown (Fig. 1B, C).
Neuronal activation in a Ba2+ bath solution may lead to cyotplasmic accumulation of Ba2+
without subsequent clearance (Mironov and Usachev, 1990), which may affect cellular
processes such as secretion (TerBush and Holz, 1992), Ca2+ release from stores (Hardcastle
et al., 1985), and VGCC function (Tang et al., 2012). To limit Ba2+ accumulation and to
assure that any Ca2+ released from stores did not participate in CaMKII activation, we also
tested the effect of KN-93 during greater divalent cation buffering (TerBush and Holz,
1992). With a pipette solution containing 11mM EGTA, calculated free Ca2+ was 21nM,
and a total Ba2+ load as large as 1μM would result in a free Ba2+ level of only 7.4nM. Under
these conditions, we confirmed that KN-93 (1μM) reduced ICa while KN-92 had no effect
(Fig. 1D). Additional buffering (pipette Ca2+ to 6nM) using BAPTA produced comparable
results (Fig. 1E). These data indicate that ICa is sensitive to KN-93 inhibition of CaMKII
across a range of experimental conditions, and indicate that ongoing Ca2+-CaM-dependent
activation of CaMKII is necessary to maintain VGCC function in sensory neurons at rest.
Effect on ICa of CaMKII inhibition by mAIP application
In addition to the small molecule inhibitor KN-93, we also tested if a cell permeable peptide
CaMKII inhibitor led to alterations in ICa. A myristoylated form of the CaMKII inhibitor
AIP (Ishida et al., 1995) mimicking the autoinhibitory domain of CaMKII was selected
because it inhibits both CaMKII activation and autophosphorylated CaMKII. Bath
application of mAIP (5 μM) produced a time-dependent reduction of ICa in excess of that
seen in time controls or in neurons exposed to mCl (Fig. 2A1). After 2min of application, at
which time the selective effect of mAIP was maximal, it produced an approximately 21%
reduction in peak ICa induced by step depolarizations, whereas less than 5% ICa rundown
was seen with both mCl and vehicle (Fig. 2A2). The specific action of both KN-93 and
mAIP versus their control agents indicates that that CaMKII regulates voltage-gated ICa in
resting sensory neurons.
Since neuronal activation during DRG harvest could be a source of CaMKII activation and
thereby may artifactually disrupt baseline CaMKII signaling, we harvested additional DRGs
after initiating cardiac perfusion with ice-cold artificial CSF solution containing (in mM):
2.5 KCl, 0.5 CaCl2, 7 MgSO4, 1.25 NaH2PO4, 26 NaHCO3, 2 EGTA, 25 Glucose, and 230
sucrose, saturated with 95% O2 and 5% CO2. The response to mAIP in these neurons did
(Fig. 2A2) not differ from recordings made in neurons harvested in the conventional way.
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We additionally tested CaMKII blockade under more physiological conditions using Ca2+ as
the charge carrier in the bath (Fig. 2A3), and identified a persisting, although reduced, effect
of mAIP on ICa under these conditions.
The normal action potential (AP) of sensory neuron somata is only a few milliseconds long
(Sapunar et al., 2005), so conventional step depolarizations lasting hundreds of milliseconds
do not reflect the typical depolarization encountered by a resting neuron. Accordingly, the
effects of mAIP and mCl were additionally tested using an AP waveform voltage command,
delivered to resting neurons. The temporal pattern of ICa evoked in this fashion matched
prior observations, with peak inward current occurring during the repolarizing limb of the
AP (Fig. 2B1). Two measurements were made to characterize ICa elicited by an AP-
waveform command. Peak ICa amplitude was inhibited by mAIP, but not by mCl (Fig. 2B2).
Similarly, the total charge transfer QCa, determined as the area under the curve for ICa
against time, was inhibited only by mAIP (Fig. 2B3). These findings indicate that CaMKII
regulates currents generated when a resting sensory neuron is activated in a physiologically
relevant fashion.
In addition to the effects we had so far observed with CaMKII inhibition for 2 to 5 minutes,
we also considered whether there might be a mode of action of CaMKII that takes longer to
reverse. We therefore examined total ICa induced by step depolarization in resting neurons
that had been incubated in mAIP (5μM) for 2 hours, and compared to neurons incubated in
the same concentration of mCl, as well as time controls. Under these conditions, peak
current was depressed by mAIP, whereas mCl had no effect (Fig. 2C). The approximate
29% depression of ICa by mAIP in this incubation experiment is somewhat larger than the
approximately 21% loss of current in the 2 minute application, suggesting that prolonged
CaMKII suppression may further reduce ICa, although direct statistical comparison between
these protocols is not possible.
Effect of CaMKII inhibition on biophysical parameters of ICa
As a first step in characterizing the mechanism of CaMKII action on VGCCs, we examined
the influence of CaMKII inhibition on voltage and conductance parameters derived from
Boltzmann analysis. Boltzmann fit of the averaged normalized currents (Fig. 3A) showed a
small depolarizing shift in V1/2 for ICa activation after mAIP application compared to mCl
application and time controls, with no effect on slope factor k. Further analysis of the
influence of mAIP by determining Boltzmann parameters for each neuron showed that
mAIP reduced GMax by 0.37±0.10pS/pF (n=12), in contrast to time controls (reduced by
0.08±0.05pS/pF, n=16; P<0.01 vs. mAIP), whereas there was no difference from controls in
neurons treated with mCl (reduced by 0.20±0.04pS/pF, n=14). This analysis confirms the
reduction in peak currents noted above. There was no effect of CaMKII inhibition on VR or
k (data not shown). A small depolarizing shift of V1/2 for channel activation was confirmed
during mAIP application (1.9±0.6mV, n=12), in contrast to controls (decreased 1.4±0.4mV,
n=16; P<0.001) and mCl (decreased 2.3±0.3mV, n=14; P<0.001). The small extent of this
shift suggests that the predominant effect of CaMKII upon VGCCs involves modulation of
channel conductance or open probability.
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Subtypes of ICa sensitive to CaMKII action
We next sought to distinguish the effects of CaMKII inhibition upon distinct VGCC
subtypes to identify if CaMKII action is necessary for maintaining performance of all, or
only a subset, of specific VGCCs in resting sensory neurons. Low-voltage-activated (LVA)
T-type currents are present in sensory neurons, in which they support excitability
(McCallum et al., 2003; Nelson et al., 2005). We therefore examined the effect of mAIP
upon T-type ICa, isolated by application HVA current blockers and evoked by
depolarizations to −30mV. Despite previous findings for CaMKII regulation of LVA
currents in expression systems (Welsby et al., 2003; Wolfe et al., 2002), we did not observe
that CaMKII activity was required for full expression of resting LVA currents in sensory
neurons (Fig. 3B).
Our previous investigations showed that CaMKII-dependent facilitation of ICa following
intense neuronal activity depended specifically upon N-type channels (Tang et al., 2012). To
identify whether the actions of CaMKII in resting sensory neurons are VGCC subtype
specific, we examined the sensitivity to mAIP of N-type and L-type currents, which
constitute the majority of sensory neuron ICa (McCallum et al., 2011). To isolate N-type
current, neurons were incubated (30min) in a combination of agents that blocked other
subtypes (nisoldipine for L-type, SNX-482 for R-type, and temporary application of ω-
conotoxin MVIIC for P/Q type). Thereafter, application of mAIP eliminated 24.2±2.6% of
the residual current evoked by step depolarizations, whereas time controls showed only a
3.1±2.8% current loss (P<0.001). Because mCl produced no effects in any prior
experiments, mCl was not further examined as a control. Subsequent application of N-type
blocker SNX-111 (200nM, 5min) eliminated all but 18.7±2.6% of the pre-mAIP baseline
current and 24.1±2.3% in time controls (n.s.). We calculated the action of mAIP selectively
on N-type current by excluding the ICa that remained following terminal SNX-111
application, which showed significant suppression by mAIP for step depolarizations, as well
as for N-type current evoked by AP-waveform commands (Fig. 3C).
As a complementary approach, we next eliminated N-type current by SNX-111 application
and then examined the sensitivity of the remaining current to mAIP. SNX-111 blocked a
major component of total ICa (during step depolarization, 63.4±1.8% of peak current, n=15;
during AP-waveform depolarization, 67.9±1.6% of peak current and 67.5±1.6% of QCa,
n=15). Application of mAIP thereafter had no effect (Fig. 3D), indicating that N-type block
precludes the effect of CaMKII inhibition. We also performed the reciprocal experiment of
first blocking L-type current. Nisoldipine blocked 26.7±2.3% of ICa induced by step
depolarizations (n=32), after which mAIP still reduced the residual current by approximately
25% of (Fig. 3E). In a small number of neurons depolarized by AP waveforms, depression
of ICa by mAIP (19.0±0.7% of peak current and 31.5±0.6% of QCa, n=3) was similarly
retained following nisoldipine treatment. Together, these findings indicate that the dominant
effect of CaMKII is on N-type currents.
Previous work on hippocampal pyramidal neurons has shown that CaMKII has an important
effect on channel kinetics such that inhibiting CaMKII accelerates P/Q-type ICa inactivation
of CaV2.1 (P/Q-type) current during step depolarization of a resting neuron (Jiang et al.,
2008). To identify if the same is true regarding the action of CaMKII on N-type current in
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resting sensory neurons, we evaluated the fraction of peak current remaining after 500ms
depolarization in isolated N-type current, both before and after application of mAIP. No
change was seen in the fraction of sustained current for either mAIP (0.71±0.02 before
mAIP, 0.68±0.02 after mAIP, n=10, P=0.24) or in time controls (0.72±0.01 first
determination, 0.72±0.02 second determination, n=12; P=0.96). This indicates that CaMKII
had no evident effect on N-type channel kinetics in resting neurons, and that the CaMKII
modulates activity-induced Ca2+ influx predominantly through its regulation of conductance
through N-type channels.
Effect on ICa of in vivo CaMKII inhibition by EGFP-AIP expression
To expand upon our findings from the pharmacological approaches on dissociated sensory
neurons reported above, we employed a model (Fig. 4A) in which neuronal expression of
AIP is induced in vivo through DRG injection of AAV vector in adult rats, thereby exposing
VGCCs in situ to AIP expression for 3 weeks prior to dissociation for electrophysiological
recording. This EGFP-AIP construct has previously been shown to suppress activity-induced
CaMKII action in sensory neurons (Tang et al., 2012). Control animals were subjected to
neuronal transduction in an identical fashion except that the transgene product consisted of
EGFP without the AIP peptide. A scrambled peptide was not used because of prior
validation of this construct (Bok et al., 2007; Tang et al., 2012) and the uncertain inactivity
of scrambled peptides. To confirm successful inhibition of CaMKII activity by the EGFP-
AIP transgene product, we compared the sensitivity of ICa to CaMKII blockade (bath-
applied mAIP) in neurons transduced by either EGFP-AIP versus EGFP vectors. This
showed only minimal residual CaMKII activity in neurons expressing EGFP-AIP (Fig. 4B).
Using this system, baseline ICa measures were not affected by transgene expression (Fig.
4C, D). On the basis of the particular dependence of N-type current on CaMKII identified
above and in prior experiments (Tang et al., 2012), we measured the portion of ICa in these
neurons that was sensitive to SNX-111. This revealed a 20% depression of N-type ICa in
neurons expressing EGFP-AIP compared to EGFP alone, by all three measures (Fig. 4E).
Boltzmann analysis of this SNX-111-sensitive (N-type) component showed no effect of
CaMKII inhibition by AIP on V1/2 or k (data not shown), confirming findings reported
above from acute application mAIP. Additionally, the extent of N-type (SNX-111 sensitive)
ICa inactivation during the 500ms step depolarization did not differ between the two vectors
(for EGFP-AIP, 0.48±0.05 fraction of sustained current, n=8; for EGFP, 0.53±0.05, n=13;
P=0.46), confirming our observation during acute mAIP application (above) that CaMKII
does not regulate N-type inactivation kinetics in resting neurons. Overall, these findings
indicate that sustained in vivo inhibition of CaMKII diminishes N-type ICa in resting sensory
neurons, which is accompanied by compensatory increase of other VGCC subtypes.
CaMKII activity in resting sensory neurons
Our findings imply that there is active (phosphorylated) CaMKII in resting sensory neurons.
This is consistent with our previous histological observations showing pCaMKII in DRG
sensory neurons using a phospho-specific Thr286/287 antibody (Kojundzic et al., 2010). To
additionally confirm autonomous CaMKII in resting neurons, we tested CaMKII activity in
DRG lysates using the specific peptide substrate AC2. Four DRGs were harvested from a
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control animal during cold perfusion with a solution lacking Na+ and Ca2+, in order to
minimize neuronal activation and Ca2+ influx. By in vitro determination of the Ca2+-
independent kinase activity as a fraction of total activity, we identified an autonomous ratio
(activity without Ca2+/CaM divided by activity during saturating Ca2+/CaM conditions, 3
replicate determinations) of 37±9%. This confirms ongoing kinase activity in sensory
neurons despite resting conditions.
DISCUSSION
A critical role for CaMKII in amplifying ICa in response to repetitive or sustained
depolarization of excitable cells is well documented (Hudmon et al., 2005; Lee et al., 2006;
Tang et al., 2012; Xiao et al., 1994; Yuan and Bers, 1994). However, in the absence of
preceding pulses of elevated [Ca2+]c, constitutive regulation of ion channels by CaMKII has
been observed in only a few settings, including modulation of resting state sodium channel
activity in cardiac myocytes (Yoon et al., 2009), and controlling inactivation kinetics, but
not peak current, of P/Q-type channels in hippocampal neurons (Jiang et al., 2008). For L-
type currents, this divergence of activity-induced versus constitutive CaMKII signaling is
apparent in cardiac myocytes, which show a prominent effect of CaMKII inhibition on
activity-induced ICa facilitation, whereas ICa induced immediately after a period of rest is
minimally affected (Yuan and Bers, 1994). Similarly, eliminating CaMKII interactions by
mutation of specific CaV1.2 (L-type) channel target residues in the pore-forming α1C
subunit (Blaich et al., 2010) or the auxiliary β2a subunit (Grueter et al., 2006) selectively
suppresses facilitation of ICa following prior Ca2+ influx, but does not influence the
amplitude of ICa upon initial depolarization of the resting membrane. Our findings contrast
with these reports in showing that unlike L- and P/Q-type channels, ongoing CaMKII
activity amplifies the function of N-type channels in resting sensory neurons, a finding that
was observed using both a small molecule and a myristoylated peptide inhibitor of CaMKII
in vitro, and confirmed using AAV transduction of the peptide inhibitor in vivo.
Our initial exploration of mechanisms by which CaMKII regulates ICa of mixed VGCCs in
resting neurons shows only a small leftward shift to lower activation voltages, as has been
previously shown for the action of CaMKII on L-type channels (Yuan and Bers, 1994).
However, this shift is minor in extent and was not observed in isolated N-type currents,
which make it likely that the main mechanism by which CaMKII increases ICa is elevation
of channel open probability, comparable to that shown in L-type channels (Dzhura et al.,
2000; Grueter et al., 2006). Unlike for P/Q current in hippocampal neurons (Jiang et al.,
2008), we did not observe accelerated current inactivation during sustained depolarization
following CaMKII inhibition. We also determined that CaMKII inhibition, both acutely in
vitro and in a sustained fashion in vivo, selectively disrupts only N-type channel activity.
Although CaMKII enhances ICa through L-type channels during depolarization of other cell
types as noted above, we found no evidence that CaMKII supports L-type ICa in resting
sensory neurons. While we did not selectively examine P/Q-current modulation in the
present study, we have previously shown that this current subtype comprises only
approximately 15% of total voltage-gated ICa in sensory neurons (McCallum et al., 2011),
suggesting that these channels can not account for the percent ICa loss we have observed
with CaMKII inhibition. This conclusion is supported by the fact that elimination of N-type
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current precludes any effect of CaMKII inhibition upon ICa (Fig. 3C). Together, these data
support our conclusion that the N-type channel is the major VGCC effector of CaMKII
signaling in sensory neurons at rest, which is concordant with our previous finding in
sensory neurons of selective participation of N-type current in CaMKII-mediated facilitation
of ICa in the period immediately following intense neuronal activation and Ca2+ influx
(Tang et al., 2012).
Our results indicate that CaMKII functions to modulate N-type VGCC activity in sensory
neurons despite long intervals of neuronal quiescence. Specifically, to duplicate natural
conditions of resting sensory neurons, the dissociated neurons in our preparation rested for
at least 2 hours after plating prior to recording. To determine responses, single test
depolarizations were used at one-minute intervals, and Ca2+ influx was prevented by the use
of Ba2+ as the charge carrier in the bath. Although our previous findings show that
augmented CaMKII signaling resolves within minutes after even sustained depolarization in
a Ca2+-containing external solution (Tang et al., 2012), the neurons in our preparation
nonetheless displayed ongoing constitutive CaMKII activity. Our finding of comparable
CaMKII activity even in neurons from DRGs harvested after first perfusing the intact animal
with cold Na+-free, reduced-Ca2+ solution makes it unlikely that this basal CaMKII
signaling is a result of neuronal activation during tissue harvest, although it could represent
residual activated CaMKII persisting from prior sensory stimulation in vivo. We therefore
postulate that even with long bouts of functional dormancy that characterize healthy
peripheral sensory neurons, a basal level of CaMKII activity persists naturally in resting
neurons and is essential for maintenance of N-type channel function. How this CaMKII
activity is maintained over a long time frame without periodic [Ca2+]c spikes is unknown,
but one simple mechanism is a balance of the opposing actions of CaMKII
autophosphorylation and phosphatase activity that permits the persistence of activated (auto-
phosphorylated) CaMKII during intervals of baseline [Ca2+]c. Since KN-93 blocks only
Ca2+-calmodulin-dependent CaMKII activation and is unable to block Ca2+-independent
CaMKII activity, it is unexpected that KN-93 would inhibit CaMKII function in low [Ca2+]c
if CaMKII reactivation was strictly yoked to a traditional Ca2+-CaM activation cycle.
Although we attempted to address potential off-target KN-93 activity by always pairing
these studies with the inactive analog KN-92, one explanation for our findings is that KN-93
is inhibiting another target in low calcium. However, the fact that we see similar findings
with the peptide CaMKII inhibitor AIP supports the notion of an ongoing cycle of CaMKII
phosphorylation and dephosphorylation even in low [Ca2+]c. Whether a population of
CaMKII is targeted to a nanodomain where [Ca2+]c is adequate for calmodulin-reactivation
of CaMKII despite chelators, or whether CaMKII can be reactivated by calmodulin in
sensory neurons independent of a traditional Ca2+-calmodulin cycle, require further
investigation.
The use-dependent component of CaMKII activity provides negative feedback control of
neuronal excitability by increasing ICa (Lirk et al., 2008; Tang et al., 2012). In contrast, the
utility of sustained CaMKII activity in a resting neuron may be to maintain the calcium
signaling machinery in a ready state. In addition, a basal level of CaMKII activity may be
important as a homeostatic mechanism related to neuronal survival. A minimal level of
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CaMKII activity has been shown to be necessary to prevent the demise of various central
and peripheral neuron populations (Ashpole and Hudmon, 2011; Ashpole et al., 2012; Bok
et al., 2007), in which a critical level of CaMKII function is maintained by periodic neuronal
firing and Ca2+ entry through VGCCs (Bok et al., 2007; Catsicas et al., 1992; Furber et al.,
1987; Hegarty et al., 1997; Lipton, 1986; Ruijter et al., 1991). However, sensory neurons in
situ are naturally inactive in the absence of specific sensory stimulation (Bessou and Perl,
1969). Without ongoing electrical activity, a moderate level of basal CaMKII function may
be a means by which sensory neurons maintain pro-survival effects without requiring
regular membrane depolarizations that would confound their basic sensory function.
CaMKII is ideally designed to detect excitation events in neurons equipped with N-type
VGCCs, and to encode this into enhanced ICa (Tang et al., 2012). Our present findings
indicate that this response mode is superimposed on a base of ongoing CaMKII activity that
is independent of depolarization-related Ca2+ elevation. Since the extent of ICa loss when
CaMKII is inhibited in resting neurons is comparable to the increase of ICa when CaMKII is
activated by intense sensory neuron firing (Tang et al., 2012), it appears that the CaMKII/N-
type Ca2+ channel regulatory system has been optimized to function in the middle of its
dynamic range in resting neurons, suggesting a critical regulatory role for this system.
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ABBREVIATIONS
AAV Adeno-associated virus
AIP Autocamtide-2-related inhibitory peptide
CaMKII Calcium/calmodulin-dependent protein kinase II
DMSO Dimethyl sulfoxide
DRG Dorsal root ganglion
EGFP Enhanced GFP
EGTA Ethylene glycol tetraacetic acid
HEPES 2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonic acid
HVA High-voltage-activated
LVA Low voltage activated
mCl Myristoyl-chloride
mAIP Myristoylated autocamtide-2-related inhibitory peptide
MVIIC ω-conotoxin MVIIC
VGCCs Voltage-gated Ca2+ channels
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Figure 1.
Effect of CaMKII inhibitor KN-93 on voltage-gated ICa. (A) Sample ICa traces (top) in
response to step depolarizations (bottom) demonstrate decreased peak current during
application of KN-93 (4.57nA) compared to baseline in the same neuron (6.03nA). (B) Time
course of onset of blockade by KN-93 in comparison to KN-92 and controls exposed to
vehicle (0.1% DMSO) alone. (C) Using a standard internal pipette solution with 2.2mM
EGTA, KN-93 (“KN93”, 1μM) applied for 5 minutes decreased ICa peak (as a percentage of
baseline), compared to change in time-matched control neurons (“C”) and the application of
the inactive isomer KN-92 (“KN92”). Baseline ICa peak was 125.8±4.9pA/pF and did not
differ between treatment groups. (D) With pipette solution containing11mM EGTA, KN-93
(1μM) suppressed peak ICa, while KN-92 did not. Baseline ICa peak was 104.6±6.0pA/pF
and did not differ between treatment groups. (E) Further buffering by the addition of 20mM
BAPTA showed similar results. Baseline ICa peak was 144.9±17.1pA/pF and did not differ
between treatment groups. Data for groups are mean ± SEM; numbers in bars are n for each
group; * P<0.05, *** P<0.001 for Tukey’s test.
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Figure 2.
Effect of CaMKII inhibitor myristoylated autocamtide-2-related inhibitory peptide
(“mAIP”) on voltage-gated ICa. (A1) Peak ICa induced by step depolarization from −60mV
to 0mV was determined at baseline and each minute thereafter for neurons exposed to mAIP
(5μM), myristoyl chloride (“mCl”, 5μM), or control neurons without any agent. The
decrease in normalized ICa for mAIP maximally diverged from both other groups by 2
minutes. (A2) Summary data show that application (2min) of mAIP depressed peak ICa
evoked by step depolarizations, whereas mCl had no effect compared to time controls (“C”).
Collection of tissue in a fashion that minimized neuronal Ca2+ influx by using ice-cold
perfusate that lacked Na+ and had minimal Ca2+ (“cold harvest”) did not alter the efficacy of
mAIP compared to the conventional tissue harvest. Baseline ICa peak was 104.7±3.7pA/pF
and did not differ between groups. (A3) In a bath solution containing Ca2+ (2mM) rather
than Ba2+, mAIP again selectively blocked ICa. Baseline ICa peak was 86.4±4.8pA/pF and
did not differ between groups. (B1) Sample ICa traces (top) in response to action potential
(AP) waveform depolarizations (bottom) demonstrate depression of the peak current in the
mAIP trace (3.17nA) compared to the baseline (“BL”) trace (4.05nA). Total charge transfer
(QCa) was also depressed by mAIP (7.34nA•ms) compared to BL (9.07nA•ms). The group
of neurons treated with mAIP showed a loss of both ICa peak (B2) and QCa (B3), whereas
there were no changes in the Control (“C”) or mCl groups. Baseline ICa peak was
109.4±8.3pA/pF, while baseline QCa was 249±18pA/pF•ms, neither of which differed
between treatment groups. (C) Neurons incubated for 120min in mAIP had reduced peak ICa
induced by step depolarizations compared to Controls, whereas mCl has no effect. (Note:
Kostic et al. Page 18
Mol Cell Neurosci. Author manuscript; available in PMC 2015 September 01.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
unlike the adjacent graphs, current density rather than % change is reported in this graph
because pre-incubation values were not available to determine the effect of the agents on a
normalized basis.) Data for groups are mean ± SEM; numbers in bars are n for each group; *
P<0.05, *** P<0.001 for Tukey’s test.
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Figure 3.
CaMKII differentially regulates voltage-gated Ca2+ channel function and subtypes. (A)
Activation curves for averaged data (mean ± SEM) of each group fitted to the Boltzmann
function for neurons at baseline (A1) and following application of myristoylated
autocamtide-2-related inhibitory peptide (“mAIP”, 5μM), myristoyl chloride (“mCl”, 5μM),
or time-matched Control (A2). The V1/2 in the mAIP group was significantly (P<0.001)
shifted in a depolarizing direction (-11.4±0.3mV) compared to the mCl (15.9±0.2mV) and
time Control groups (15.5±0.3mV). (B) T-type current was measured by isolation with HVA
current blockers (20min incubation with SNX-482, 200nM, and MVIIC, 200nM, and
recording in a bath containing nimodipine, 5uM, and ω-Conotoxin GVIA, 200nM), and
Kostic et al. Page 20
Mol Cell Neurosci. Author manuscript; available in PMC 2015 September 01.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
evoking ICa by step depolarizations from a holding potential of −100mV to a test potential of
−30mV. The current peak was corrected by subtracting the sustained component (Jagodic et
al., 2008). Application of mAIP has minimal effect on peak T-type ICa that is not different
from the time control. (C) During isolation of N-type current by application of selective
blockers of other VGCC subtypes (nisoldipine 200nM for L-type, SNX-482 500nM for
components of R-type, and temporary application of ω-conotoxin MVIIC 2μM for persisting
block of P/Q-type), ICa was measured before and after exposure to mAIP, and compared to
time-matched Control neurons that were exposed only to continued application of the
VGCC blockers without added mAIP. Percent blockade was determined as the ICa blocked
by mAIP (or lost during a comparable time interval) divided by the difference between
baseline ICa and that which remained after application of SNX-111 (200nM) at the end of
each experiment, multiplied by 100. Myristoylated AIP (mAIP) decreased peak ICa elicited
by step depolarization, peak ICa during AP-waveform depolarization, and total charge
transfer (QCa) during AP-waveform depolarization. Baseline measures of step-induced peak
ICa (57.7±4.1pA/pF), AP-waveform-induced peak ICa (109.4±8.3pA/pF) and waveform-
induced QCa (249.4±17.8pA/pF•ms) did not differ between groups. (D) Prior treatment of
neurons with SNX-111 alone eliminated the effect of mAIP application on all three
measures of ICa. Baseline measures of step-induced peak ICa (101.9±7.5pA/pF), AP-
waveform-induced peak ICa (183.6±12.2pA/pF) and waveform-induced QCa
(440.1±29.0pA/pF•ms) did not differ between groups. Block of ICa by SNX-111 for these
three measures (63.4±1.8%, 67.9±1.6%, and 67.5±1.6%) did not differ between groups. (E)
Application of nisoldipine (200nM) in the recording bath did not preclude suppression of
step-evoked ICa peak by subsequently applied mAIP. Baseline peak ICa (82.9±7.1pA/pF)
and the percentage of current blocked by nisoldipine (22.4±2.2%) did not differ between
groups. Mean ± SEM; *** P<0.001 for t-tests.
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Figure 4.
In vivo blockade of CaMKII by expression of AIP. (A) The method involves injection of
adeno-associated virus (AAV) vector into the dorsal root ganglion (DRG) of the
anesthetized rat, in vivo transduction and transgene expression for 3 weeks (green, EGFP;
red, β3-Tubulin), followed by DRG harvest and neuronal dissociation for
electrophysiological study. Scale bar 50μm. (B) Neurons expressing EGFP alone (“EGFP”)
retain sensitivity of ICa to CaMKII blockade with mAIP (5μM) that is comparable to Control
neurons (Fig. 2A2), whereas neurons expressing EGFP-AIP (“AIP”) have reduced
sensitivity to CaMKII blockade. (C) Sample traces of currents elicited by step
depolarizations (top row) and by action potential (“AP”) waveform commands (currents in
middle row, voltage commands in the bottom row) show ICa at baseline (“BL”), ICa in the
same neuron after N-type ICa block with SNX-111 (200nM), and the difference current
sensitive to SNX-111 obtained by subtraction. Recordings are shown from a neuron
expressing only EGFP (left) and another expressing EGFP-AIP (right). (D) Neurons
expressing either EGFP alone (“EGFP”) or EGFP-AIP (“AIP”) did not differ in peak ICa
measured by step depolarization (left bars) or AP waveform depolarization (middle bars),
and charge transfer (QCa) was also unaffected (right bars, ordinate scale to the right). (E)
Block of ICa by SNX-111 application was compared in neurons expressing EGFP alone or
EGFP-AIP. Less ICa blockade (i.e. less N-type ICa) was evident in neurons expressing
EGFP-AIP by all three measures. Mean ± SEM; * P<0.05 for t-tests.
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